Legacy R&D Operations Are the Real Bottleneck in MedTech Innovation—And It’s Time to Face It
The medical device industry is at a pivotal crossroads where technological innovation—driven by AI, connected devices, and software platforms—is surging ahead, yet the operational backbone that should support this progress…
AI Medical Scribes: A Promising Yet Premature Panacea for Clinician Burnout
The advent of AI medical scribes is undoubtedly a technological milestone, but healthcare marketers and industry professionals must resist the temptation to oversell their immediate impact. While the allure of…
Digital Therapeutics: The Most Promising Digital Health Revolution You’re Ignoring at Your Own Risk
Digital Therapeutics (DTx) is no passing fad like the Metaverse or NFTs; it is the digital health innovation sector that healthcare marketers and medical professionals must prioritize now. Unlike vague…
Pharma’s Digital Health Renaissance: Beyond ROI to Radical Patient-Centric Innovation
The pharmaceutical industry stands at a pivotal crossroads where digital health technologies aren’t just optional add-ons but existential imperatives. The eight trends outlined—from AI-driven drug discovery to in silico clinical…
When Medical Innovation Crosses the Line: A Critical Look at Creepy Tech in Healthcare
The relentless march of medical technology often promises to revolutionize healthcare, but as industry professionals, we must pause and critically evaluate when innovation becomes unsettling or ethically questionable. The examples…
Patient Engagement Forums Are Talking, But Are They Driving Real Change?
The recent online meeting between the Clinical Trials Transformation Initiative (CTTI)/FDA Patient Engagement Collaborative (PEC) and the European Medicines Agency (EMA) Patients and Consumers Working Party (PCWP) highlights a persistent…
Patient Engagement Collaboratives Are Talking—but Are They Driving Real Change?
The upcoming joint meeting between the CTTI/FDA Patient Engagement Collaborative (PEC) and the EMA Patients and Consumers Working Party (PCWP) is being heralded as a milestone in cross-continental patient involvement.…
When Activist Investors Dictate Healthcare Leadership: The Case of STAAR’s Board Shakeup
The recent overhaul at STAAR, driven by an activist investor that resulted in the ousting of both the CEO and board chair, is more than just another headline in healthcare…
The ‘Great Healthcare Plan’: A Missed Opportunity Cloaked in Vagueness
The so-called ‘Great Healthcare Plan’ is emblematic of a broader issue in healthcare policy communication: ambiguity that hinders strategic marketing and stakeholder engagement. For healthcare marketers, clarity is non-negotiable. This…
Strategic Leadership: The Overhyped Panacea or the Real Catalyst for Healthcare’s Future?
The current industry obsession with “strategic leadership” in healthcare risks becoming a buzzword devoid of actionable insight. While the article rightly positions leadership as central to progress, it stops short…